Abstract:Purpose Inpatient glycemic management has become a common issue because of the increasing number of hospitalized patients with hyperglycemia. Point-of-care devices can enable timely inpatient glucose monitoring, which may lead to better outcomes. The accuracy of point-of-care testing in various clinical scenarios has been questioned, particularly in neonates and critically ill patients. This study aimed to evaluate the accuracy of the CONTOUR PLUS and CONTOUR PLUS ONE glucometers (new wireless systems that link to a smart mobile device) when used as point-of-care devices for blood glucose monitoring in neonates and critically ill adults in inpatient settings. Methods This cross-sectional study was conducted at a medical center in central Taiwan and enrolled patients admitted to the neonatal intensive care unit, sick child room, or respiratory intensive care unit between November 2020 and April 2021. Neonates with suspected infection or abnormal blood coagulation and adults who had abnormal blood coagulation, were pregnant, had received organ transplants, or had undergone massive blood transfusions were excluded. The accuracy of the glucometers was determined based on the following criteria of the International Organization for Standardization (ISO) standard: 15197:2013. Findings Overall, 114 neonates (mean age, 4.2 days [range, 0–28 days]; 65 boys [57.0%]) and 106 hospitalized critically ill adults (mean age, 68.2 years [range, 27–94 years]; 72 men [67.9%]) were enrolled in this study. The glucose values obtained with each glucometer had good precision, and all findings met the reference criteria of the within-lot results. All measurements of the neonates' venous blood by each glucometer met the accuracy criteria specified by ISO standard 15197:2013. Furthermore, 98.1% and 97.2% of the arterial blood glucose measurements for critically ill adults obtained with CONTOUR PLUS and CONTOUR PLUS ONE met the accuracy criteria, respectively. Implications Both glucose management systems met the accuracy criteria for venous blood from neonates and arterial blood from critically ill adults. Thus, the use of these 2 point-of-care devices in inpatient settings, including for neonates and critically ill adults, can be recommended to minimize limitations associated with the clinical application of point-of-care testing in glucose management. The wireless connection may play a role in the subsequent development of institution-wide virtual glycemic management under the supervision of a team of endocrinologists.

Analytic performance evaluation of five kinds of point-of-care testing blood glucose meters

The Quality of POCT Ensured by the Hospital's Internal Management

Comparison of POCT glucose meters and analysis of the interference factor

Differences in the System Accuracy Acceptability of Four Types of Blood Glucose Monitoring Systems Against Five Different Standards

The real world of blood glucose point-of-care testing (POCT) system running in China teaching hospital

Evaluation of Analytical Performance of Three Blood Glucose Monitoring Systems: System Accuracy, Measurement Repeatability, and Intermediate Measurement Precision

Analytical Performance Evaluation of the GreenCare A1c and Cera-Stat HbA1c Point-Of-Care Testing Assays

Monitoring of the Analytical Performance of Four Different Blood Glucose Monitoring Systems: A Post-market Performance Follow-Up Study

Assessing the Accuracy of Different Glucometers Based on the Laboratory Reference Method

Investigation of precision and trueness of the glucose results from 15 measure systems in 4 domestic factories

Evaluation of Five Routine Glucose Methods on an Olympus AU5400 Analyzer Using the CDC Hexokinase Reference Method

Accuracy of Point-of-Care Blood Glucometers in Neonates and Critically Ill Adults

System Accuracy Evaluation of 43 Blood Glucose Monitoring Systems for Self-Monitoring of Blood Glucose according to DIN EN ISO 15197

Evaluation of the precision and accuracy of the results from the 6 systems using 4 serum glucose analysis methods

Evaluation of the Medisafe glucometer' s performance

Accuracy of different blood glucose measurements in a medical intensive care unit

Accuracy Evaluation of 19 Blood Glucose Monitoring Systems Manufactured in the Asia-Pacific Region: A Multicenter Study.

Recent Developments in Personal Glucose Meters as Point-of-Care Testing Devices (2020–2024)

Verification of a novel point-of-care HbA1c device in real world clinical practice by comparison to three high performance liquid chromatography instruments.

Performance evaluation of the glycated hemoglobin A1c analyzer for point-of-care testing compared with laboratory-based devices: a multicenter validation study

Assessment of the Performance of Blood Glucose Monitoring Systems for Monitoring Dysglycaemia in Neonatal Patients.